Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

15.73

+0.17 (1.09%)

At close: Jul 21, 2026, 4:00 PM EDT

15.73

0.00 (0.00%)

After-hours: Jul 21, 2026, 4:10 PM EDT

Caris Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	4,447	7,623	-	-	-
Market Cap Growth	-47.01%	-	-	-	-
Enterprise Value	4,061	7,201	0	0	0
Last Close Price	15.73	26.98	-	-	-
Forward PE	85.12	294.73	-	-	-
PS Ratio	4.91	9.39	-	-	-
PB Ratio	7.41	2.44	-	-	-
P/TBV Ratio	1.19	1.45	-	-	-
P/FCF Ratio	36.07	113.95	-	-	-
P/OCF Ratio	30.22	91.67	-	-	-
EV/Sales Ratio	4.48	8.87	-	-	-
EV/EBITDA Ratio	31.49	106.33	-	-	-
EV/EBIT Ratio	37.48	159.63	-	-	-
EV/FCF Ratio	32.90	107.65	-	-	-
Debt / Equity Ratio	0.12	0.12	-1.15	-8.46	0.67
Debt / EBITDA Ratio	144.21	5.60	-	-	-
Debt / FCF Ratio	3.09	5.67	-	-	-
Net Debt / Equity Ratio	-0.14	-0.13	-0.12	-0.02	0.11
Net Debt / EBITDA Ratio	-167.00	-6.22	-1.50	-0.15	0.72
Net Debt / FCF Ratio	-3.58	-6.29	-1.23	-0.14	0.58
Asset Turnover	0.79	1.11	1.09	0.54	0.36
Inventory Turnover	1.96	5.29	5.27	4.52	3.80
Quick Ratio	6.35	7.17	0.94	1.90	3.31
Current Ratio	7.05	7.85	1.30	2.55	3.77
Return on Equity (ROE)	-2.31%	-4.78%	189.92%	-293.83%	-127.28%
Return on Assets (ROA)	-1.58%	6.14%	-67.96%	-56.54%	-44.01%
Return on Invested Capital (ROIC)	-0.67%	3.13%	-103.66%	-168.80%	-518.91%
Return on Capital Employed (ROCE)	-1.78%	7.67%	-103.66%	-71.15%	-54.39%
FCF Yield	2.77%	0.88%	-	-	-
Buyback Yield / Dilution	-543.56%	-371.05%	-1.59%	-104626.10%	-
Total Shareholder Return	-543.56%	-371.05%	-1.59%	-104626.10%	-

SEC Filings: 10-K · 10-Q